answersLogoWhite

0


Best Answer

Linoleic acid is believed to be helpful because myelin is composed of lecithin , which is made of linoleic and other fatty acids.

User Avatar

Wiki User

13y ago
This answer is:
User Avatar

Add your answer:

Earn +20 pts
Q: Does lecithin aid in treating symptoms of multiple sclerosis?
Write your answer...
Submit
Still have questions?
magnify glass
imp
Related questions

What are the various therapies for multiple sclerosis?

Treatment for multiple sclerosis consists of treating the symptoms and preventing permanent damage. Teatments may include medications, physical and occupational therapy and experimental therapies.


What does cannabis offer for medical treatments?

There are a number of things that cannabis is currently being used for in regards to medical treatments. It has been found to relieve some symptoms of multiple sclerosis and spinal injuries due to the muscle relaxing properties. It is also used for treating bipolar disorder, depression, skin tumors and sleep apnea.


What is the most recent scientific discovery?

I get a newsletter with at least 20 new discoveries in one day. However one stood out since I am interested in MS.By combining a brain-protein gene and an existing medication, the researchers were able to prevent the mouse version of multiple sclerosis. Likewise, the treatments produced near-complete remission in the animal models. The findings, which researchers said have significant potential for treating multiple sclerosis and other autoimmune disorders, are published in the journal Molecular Therapy.


Multiple Sclerosis - Treating An Exacerbation?

Multiple sclerosis is a progressive disorder of the central nervous system. The disease is believed to be of an autoimmune nature. The body attacks the protective myelin sheaths around nerves, causing them to short circuit. Those with the disease may face a myriad of symptoms, including muscle weakness, numbness, visual disturbances or bowel problems. It can affect anyone, but it is usually diagnosed in young adults who are in their late twenties and thirties. Women are afflicted with this disorder more than men. In the early years of the disease, patients may experience symptoms that come and go, known as a multiple sclerosis exacerbation. These events are treated through a few different procedures, with a complete remission being the hopeful outcome. The first line of treatment for a multiple sclerosis exacerbation is usually a 3 to 5 day course of intravenous steroids. These drugs work to reduce the inflammation around current disease activity, which can be seen on an MRI scan. For some, IV steroids work quickly, reversing symptoms within a matter of days. Others, however, may not respond to the treatment. Steroids work by shortening the duration of the exacerbation; they do no change the outcome. Some symptoms may go away completely, while others may leave behind residual damage. Frequent steroid use can cause many complications, including weight gain and even diabetes. A health care provider will help manage any side effects. For those who do not respond to steroids, another treatment option is plasma exchange therapy. During this treatment, the blood is separated from the plasma. The plasma that is transferred back into the patient is cleaned of all harmful substances that may interact negatively with the immune system. Those who have undergone this medical procedure have seen their symptoms greatly reduced. It does not work in all instances, however. There is no way of telling which patients may benefit from plasma exchange. While both intravenous steroids and plasma exchange are accepted treatments for an acute multiple sclerosis exacerbation, it is still best to manage the disorder with one of the disease modifying drugs. Those with multiple sclerosis should also follow a healthy diet and regular exercise regimen. While there is no cure for MS, there are many treatments available to patients to reduce flare-ups or treat existing symptoms. Having an open line of communication with a multiple sclerosis specialist is important for those living with the disease.


What is the primary means of mitigating or treating mild or severe symptoms of nerve agent?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary of mitigating or treating mild or severe symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary means of mitigating or treating mild of severe symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposures?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is primary means of mitigating or treating mild or sever symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary means of mitigating or treating mild severe symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary means of mitigation or treating mild or severe symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.


What is the primary mean of mitigating or treating mild or severe symptoms of nerve agent exposure?

Administer antidote and anticonvulsant auto-injections is the primary means of mitigating or treating mild or severe symptoms of nerve agent exposure.